Quinone-Containing Conjugates for Novel Therapeutic and Diagnostic Applications
Legal Citation
Summary of the Inventive Concept
The present disclosure relates to the application of quinone-containing conjugates to new therapeutic and diagnostic areas, including neurological disorders, skin conditions, and cardiovascular diseases, enabling targeted treatment and detection.
Background and Problem Solved
The original patent disclosed quinone-containing conjugates for the treatment of proliferative disorders. However, these conjugates were limited to a specific application. The present inventive concept addresses the need for more versatile and adaptable conjugates that can be applied to a broader range of therapeutic and diagnostic areas.
Detailed Description of the Inventive Concept
The quinone-containing conjugates of formula (I) are adapted for use in novel therapeutic and diagnostic applications. The conjugates selectively target and destroy cells associated with neurological disorders, skin conditions, and cardiovascular diseases. The conjugates can be linked to detection agents for biomarker detection or used as therapeutic agents for targeted treatment. The conjugates' versatility is demonstrated by their ability to be administered in various forms, including compositions and kits.
Novelty and Inventive Step
The new claims introduce novel therapeutic and diagnostic applications for quinone-containing conjugates, which were not contemplated in the original patent. The inventive concept lies in the recognition of the conjugates' potential in these new areas and the adaptation of the conjugates to address specific challenges in these fields.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept include variations in the linker, payload, and cell-binding moiety to optimize the conjugates for specific applications. Additionally, the conjugates could be used in combination with other therapeutic agents or detection methods to enhance their effectiveness.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical and diagnostic industries, with applications in neurological disorders, skin conditions, and cardiovascular diseases. The market for these applications is substantial, and the quinone-containing conjugates offer a promising solution for targeted treatment and detection.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K47/6889 |
| A | A61 | A61K31/122 |
| A | A61 | A61K47/6891 |
| A | A61 | A61K49/0039 |
| A | A61 | A61K49/0043 |
| A | A61 | A61K49/0052 |
| C | C07 | C07D417/12 |
| C | C07 | C07K16/30 |
| G | G01 | G01N33/582 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical chemistry, specifically antibody-drug conjugates (ADCs) and targeted therapeutic/diagnostic molecular design, involving organic synthesis, biochemistry, and molecular targeting techniques
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degree (PhD) in chemistry or pharmaceutical sciences, expertise in bioconjugate design, understanding of molecular linker chemistry, cell targeting strategies, and therapeutic agent modification techniques
Obviousness Rationale
A PHOSITA would recognize the quinone-containing conjugates disclosed in the PTD as predictable extensions of the source patent's ADC technology, leveraging known molecular design principles to adapt the core conjugate structure for alternative therapeutic and diagnostic applications by modifying targeting and payload strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,638 |
|---|---|
| Title | Quinone-containing conjugates |
| Assignee(s) | Promega Corporation |